raltitrexed


Also found in: Wikipedia.

raltitrexed

A folate analogue drug used in the palliative treatment of advanced cancer of the colon or rectum. A brand name is Tomudex.
Mentioned in ?
References in periodicals archive ?
The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.
[7] Another antifolate agent raltitrexed that has similar efficacy to pemetrexed can also be considered to reduce the cost related to treatment.
Ltd., Wuxi, China) and raltitrexed (Chia Tai Tianqing Pharm Co., Ltd., Nanjing, China) in four patients and oxaliplatin and raltitrexed (Sanofi Pharm Co.
Contract awarded for supply of raltitrexed 2mg vials
The rest of the three studies were used CKI plus OXA + CF, OXA + Raltitrexed (RA), Irinotecan (IR) + CF + 5FU, respectively.
Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada.
A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotekan, oxalyplatin and raltitrexed for the treatment of advanced colorectal cancer, Health Technology Assessment NHS R&D HTA Program, Health Technol Assess.
Hietschold, Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer.
Bruzzese et al., "Synergistic antitumour effect of raltitrexed and 5-fluorouracil plus folinic acid combination in human cancer cells," Anti-Cancer Drugs, vol.
Severe enteropathy associated with raltitrexed and oxaliplatin chemotherapy: report of two patients experiencing this rare, potentially lethal gastrointestinal adverse event.
Selected Drugs Associated With Treatment-Induced Diarrhea Older Agents Targeted Biologics New Compounds * 5-FU-based regimens Lapatinib (plus Histone deacetylase capecitabine) inhibitors (chidamide) Capecitabine Erlotinib Heat shock protein 90 inhibitor (AUY922) Irinotecan Cetuximab, Raf kinase inhibitor panitumumab (XL281) Taxanes Sorafenib, Proteasome inhibitor sunitinib (carfilzomib) Cisplatin Bortezomib Methotrexate Imatinib Raltitrexed * Reported at ASCO 2009 to have dose-limiting toxicity.
Framework agreement with a single operator per lot for provision of medicines Urokinase Raltitrexed, Entecavir and Somatostatin for Service Organizations Osakidetza